After developing pan‑ureteritis following endoscopic combined intrarenal surgery (ECIRS), what measures should be taken to prevent progression to a ureteral stricture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Immediate Ureteral Stenting and Close Monitoring

After developing pan-ureteritis following ECIRS, you must immediately place a ureteral stent to prevent stricture formation, maintain drainage, and preserve renal function, with mandatory close follow-up for at least one year.

Immediate Management

The priority is preventing progression to stricture through early intervention:

  • Place a ureteral stent immediately if not already done. Stenting is essential to maintain ureteral patency during the inflammatory healing phase and prevent stricture formation 1. The stent acts as a scaffold to prevent luminal collapse while inflammation resolves.

  • Ensure adequate urinary drainage - this is the fundamental principle in managing any ureteral injury or inflammation 2. Consider nephrostomy tube placement if retrograde stenting fails or is not feasible.

  • Initiate appropriate antibiotic therapy if infection is present, as ureteritis is often infectious and can be caused by E. coli, staphylococci, streptococci, or other urinary pathogens 1.

Risk Stratification

Assess your patient's risk factors for stricture development:

High-risk features include:

  • Severe hydronephrosis (10-fold increased risk) 3
  • Intraoperative ureteral injury (1776-fold increased risk) 3
  • Residual stone fragments (47-fold increased risk) 3
  • Long segment involvement
  • Moderate-to-severe hydronephrosis 4

If your patient has any of these features, they require even more aggressive monitoring and potentially longer stenting duration.

Stenting Duration and Strategy

  • Maintain the stent for an extended period - typically several weeks to months depending on severity of inflammation. The evidence shows that stenting is necessary to preserve renal function in chronic ureteritis with stricture risk 1.

  • Consider nephrostomy alone rather than double-J stent if feasible, as this may reduce patient discomfort during recovery. Recent data shows nephrostomy-only drainage can be effective post-ECIRS without increasing complications 5.

Surveillance Protocol

Monitor for stricture formation for at least one year 6. This is critical as most strictures develop within the first year after ureteral injury or inflammation.

Surveillance should include:

  • Serial renal ultrasounds to detect hydronephrosis
  • Uroflowmetry if lower tract involvement
  • CT urography (gold standard) if stricture suspected 2
  • Serum creatinine monitoring for renal function

Specific timing:

  • Initial ultrasound at 1 month post-stent removal
  • Repeat imaging at 3,6, and 12 months
  • Earlier imaging if symptoms develop (flank pain, fever, decreased urine output)

Emerging Preventive Strategy

Paclitaxel-coated balloon dilation is a promising approach for preventing stricture formation, with an 86.2% success rate in recent evidence 7. While this is typically used for established strictures, it may have a role in high-risk cases with severe inflammation. However, this requires specialized equipment and expertise 8, 7.

Common Pitfalls to Avoid

  • Do not remove the stent too early - premature stent removal before inflammation resolves increases stricture risk
  • Do not assume resolution without imaging - strictures can develop silently without symptoms until significant obstruction occurs
  • Do not delay intervention if stricture develops - early endoscopic management (if stricture ≤2 cm, proximal/distal location, mild-moderate hydronephrosis) has better outcomes than delayed treatment 4
  • Do not ignore mild hydronephrosis - this may be the first sign of developing stricture

If Stricture Develops Despite Prevention

If stricture forms despite these measures:

  • Endoscopic management first if stricture is ≤2 cm, located proximally or distally, with mild-to-moderate hydronephrosis (success rate 51.6%) 4
  • Surgical reconstruction if endoscopic approach fails or stricture is long-segment, complex, or associated with severe hydronephrosis (success rate 95.7%) 4
  • The median time to recurrence after endoscopic treatment is 51 months, so extended surveillance beyond one year may be warranted 4

The key is aggressive early stenting, treating any infection, and maintaining close surveillance to catch stricture formation early when endoscopic intervention is most likely to succeed.

References

Research

[Ureteritis].

Archivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell'Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences, 1993

Guideline

urotrauma: aua guideline.

The Journal of urology, 2014

Research

Ureteral Stricture: Endoscopic Management.

European urology focus, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.